drugset / Trial / NCT06911320
Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic Function
Non-randomizedParallel-groupOpen-labelTreatment
Summary
To Assess the Effect of Severe Hepatic or Renal Impairment on the Pharmacokinetics of Bemnifosbuvir/Ruzasvir After a Single Dose
Timeline
- Start
- 2025-04-09
- Primary completion
- 2026-05
- Completion
- 2026-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bemnifosbuvir | Other / unclassified | — | — |
| Subject | Ruzasvir | Other / unclassified | — | — |